166 related articles for article (PubMed ID: 8076426)
1. Vascular endothelin responsiveness and receptor characteristics in vitro and effects of endothelin receptor blockade in vivo in cyclosporin hypertension.
Phillips PA; Rolls KA; Burrell LM; Casley D; Aldred KL; Hardy KJ
Clin Exp Pharmacol Physiol; 1994 Mar; 21(3):223-6. PubMed ID: 8076426
[TBL] [Abstract][Full Text] [Related]
2. Vasoconstrictor responses to components of the renin-angiotensin system in cyclosporin-induced hypertension in the rat.
Rolls KA; Phillips PA; Aldred K; Hardy KJ
Clin Exp Pharmacol Physiol; 1994 Mar; 21(3):227-30. PubMed ID: 8076427
[TBL] [Abstract][Full Text] [Related]
3. Effects of selective endothelin antagonists on the hemodynamic response to cyclosporin A.
Davis LS; Haleen SJ; Doherty AM; Cody WL; Keiser JA
J Am Soc Nephrol; 1994 Jan; 4(7):1448-54. PubMed ID: 8161726
[TBL] [Abstract][Full Text] [Related]
4. Role of endothelin in the control of peripheral vascular tone in human hypertension.
Taddei S; Virdis A; Ghiadoni L; Sudano I; Magagna A; Salvetti A
Heart Fail Rev; 2001 Dec; 6(4):277-85. PubMed ID: 11447302
[TBL] [Abstract][Full Text] [Related]
5. Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension.
Fujita K; Matsumura Y; Kita S; Miyazaki Y; Hisaki K; Takaoka M; Morimoto S
Br J Pharmacol; 1995 Mar; 114(5):925-30. PubMed ID: 7780646
[TBL] [Abstract][Full Text] [Related]
6. Endothelin receptor function in mesenteric veins from deoxycorticosterone acetate salt-hypertensive rats.
Johnson RJ; Fink GD; Watts SW; Galligan JJ
J Hypertens; 2002 Apr; 20(4):665-76. PubMed ID: 11910302
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib, but not indomethacin, ameliorates the hypertensive and perivascular fibrotic actions of cyclosporine in rats: role of endothelin signaling.
El-Mas MM; Helmy MW; Ali RM; El-Gowelli HM
Toxicol Appl Pharmacol; 2015 Apr; 284(1):1-7. PubMed ID: 25656942
[TBL] [Abstract][Full Text] [Related]
8. Comparison of effect of endothelin antagonism and angiotensin-converting enzyme inhibition on blood pressure and vascular structure in spontaneously hypertensive rats treated with N omega-nitro-L-arginine methyl ester. Correlation with topography of vascular endothelin-1 gene expression.
Li JS; Deng LY; Grove K; Deschepper CF; Schiffrin EL
Hypertension; 1996 Aug; 28(2):188-95. PubMed ID: 8707380
[TBL] [Abstract][Full Text] [Related]
9. Endothelin subtype B receptor-mediated calcium and contractile responses in small arteries of hypertensive rats.
Touyz RM; Deng LY; Schiffrin EL
Hypertension; 1995 Dec; 26(6 Pt 2):1041-5. PubMed ID: 7498964
[TBL] [Abstract][Full Text] [Related]
10. Endothelin receptors mediating vasoconstriction in rat pressurized small arteries.
Sharifi AM; Schiffrin EL
Can J Physiol Pharmacol; 1996 Aug; 74(8):934-9. PubMed ID: 8960383
[TBL] [Abstract][Full Text] [Related]
11. Contribution of endothelin receptors in renal microvessels in acute cyclosporine-mediated vasoconstriction in rats.
Cavarape A; Endlich K; Feletto F; Parekh N; Bartoli E; Steinhausen M
Kidney Int; 1998 Apr; 53(4):963-9. PubMed ID: 9551405
[TBL] [Abstract][Full Text] [Related]
12. Losartan but not verapamil inhibits angiotensin II-induced tissue endothelin-1 increase: role of blood pressure and endothelial function.
d'Uscio LV; Shaw S; Barton M; Lüscher TF
Hypertension; 1998 Jun; 31(6):1305-10. PubMed ID: 9622146
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists.
Watts SW; Fink GD; Northcott CA; Galligan JJ
Br J Pharmacol; 2002 Sep; 137(1):69-79. PubMed ID: 12183332
[TBL] [Abstract][Full Text] [Related]
14. Endothelin receptors mediating contraction of rat and human pulmonary resistance arteries: effect of chronic hypoxia in the rat.
McCulloch KM; Docherty C; MacLean MR
Br J Pharmacol; 1998 Apr; 123(8):1621-30. PubMed ID: 9605569
[TBL] [Abstract][Full Text] [Related]
15. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles.
Lanese DM; Conger JD
J Clin Invest; 1993 May; 91(5):2144-9. PubMed ID: 8486781
[TBL] [Abstract][Full Text] [Related]
16. Role of endothelin in regulation of resistance, fluid-exchange, and capacitance functions of the systemic circulation.
McNeill JR
Can J Physiol Pharmacol; 2003 Jun; 81(6):522-32. PubMed ID: 12839264
[TBL] [Abstract][Full Text] [Related]
17. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
Schiffrin EL; Turgeon A; Deng LY
Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of PABSA, an orally active and highly potent endothelin-receptor antagonist.
Iwasaki T; Mihara S; Shimamura T; Kawakami M; Hayasaki-Kajiwara Y; Naya N; Fujimoto M; Nakajima M
J Cardiovasc Pharmacol; 1999 Jul; 34(1):139-47. PubMed ID: 10413080
[TBL] [Abstract][Full Text] [Related]
19. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.
Warner TD; Allcock GH; Vane JR
Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643
[TBL] [Abstract][Full Text] [Related]
20. Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists.
Allcock GH; Warner TD; Vane JR
Br J Pharmacol; 1995 Nov; 116(5):2482-6. PubMed ID: 8581288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
